Literature DB >> 19624385

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.

Mauricio Tohen1, Ellen Frank, Charles L Bowden, Francesc Colom, S Nassir Ghaemi, Lakshmi N Yatham, Gin S Malhi, Joseph R Calabrese, Willem A Nolen, Eduard Vieta, Flávio Kapczinski, Guy M Goodwin, Trisha Suppes, Gary S Sachs, Kn Roy Chengappa, Heinz Grunze, Philip B Mitchell, Shigenobu Kanba, Michael Berk.   

Abstract

OBJECTIVES: Via an international panel of experts, this paper attempts to document, review, interpret, and propose operational definitions used to describe the course of bipolar disorders for worldwide use, and to disseminate consensus opinion, supported by the existing literature, in order to better predict course and treatment outcomes.
METHODS: Under the auspices of the International Society for Bipolar Disorders, a task force was convened to examine, report, discuss, and integrate findings from the scientific literature related to observational and clinical trial studies in order to reach consensus and propose terminology describing course and outcome in bipolar disorders.
RESULTS: Consensus opinion was reached regarding the definition of nine terms (response, remission, recovery, relapse, recurrence, subsyndromal states, predominant polarity, switch, and functional outcome) commonly used to describe course and outcomes in bipolar disorders. Further studies are needed to validate the proposed definitions.
CONCLUSION: Determination and dissemination of a consensus nomenclature serve as the first step toward producing a validated and standardized system to define course and outcome in bipolar disorders in order to identify predictors of outcome and effects of treatment. The task force acknowledges that there is limited validity to the proposed terms, as for the most part they represent a consensus opinion. These definitions need to be validated in existing databases and in future studies, and the primary goals of the task force are to stimulate research on the validity of proposed concepts and further standardize the technical nomenclature.

Entities:  

Mesh:

Year:  2009        PMID: 19624385     DOI: 10.1111/j.1399-5618.2009.00726.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  79 in total

Review 1.  Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

Authors:  Frederick K Goodwin; Elizabeth A Whitham; S Nassir Ghaemi
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

2.  Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.

Authors:  Erika Fh Saunders; Aubrey Reider; Gagan Singh; Alan J Gelenberg; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2015-10-01       Impact factor: 6.744

Review 3.  New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions.

Authors:  Chantal Henry; Bruno Etain
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

4.  Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial.

Authors:  Diego F Tavares; Martin L Myczkowski; Rodrigo L Alberto; Leandro Valiengo; Rosa M Rios; Pedro Gordon; Bernardo de Sampaio-Junior; Izio Klein; Carlos G Mansur; Marco Antonio Marcolin; Beny Lafer; Ricardo A Moreno; Wagner Gattaz; Zafiris J Daskalakis; André R Brunoni
Journal:  Neuropsychopharmacology       Date:  2017-02-01       Impact factor: 7.853

5.  Systematic Review of Symptom Assessment Measures for Use in Measurement-Based Care of Bipolar Disorders.

Authors:  Joseph M Cerimele; Simon B Goldberg; Christopher J Miller; Stephen W Gabrielson; John C Fortney
Journal:  Psychiatr Serv       Date:  2019-02-05       Impact factor: 3.084

6.  [Acute and long-term treatment for bipolar depression].

Authors:  H Grunze; S Dargel
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

Review 7.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

8.  Elevated striatal reactivity across monetary and social rewards in bipolar I disorder.

Authors:  Sunny J Dutra; William A Cunningham; Hedy Kober; June Gruber
Journal:  J Abnorm Psychol       Date:  2015-09-21

9.  LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder.

Authors:  Rodolfo N Campos; Luis F Costa; Danielle S Bio; Márcio G Soeiro de Souza; Carla R L Garcia; Frederico N Demétrio; Doris H Moreno; Ricardo A Moreno
Journal:  Trials       Date:  2010-06-23       Impact factor: 2.279

10.  Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.

Authors:  Michael Maes; Joao Victor Nani; Cristiano Noto; Lucas Rizzo; Mirian A F Hayashi; Elisa Brietzke
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.